Clinical Development Programme of the Innovative Mesenchymal Stromal Cell Product MSC-FFM/MC0518 for Steroid-Refractory Acute Graft-Versus-Host Disease: Design of 2 Randomised Controlled Trials in Adult and Paediatric Patients.
来源：PubMed发布日期：2026-06-01作者：Zeiser R, Bönig H, Osswald E, Pichlmeier U, Möller AK0 次点击